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Bone tissue loss due to injury or disease often requires application of autologous tissue grafts
or artificial biomaterials to fill the fracture. Synthetic biomaterials provide temporary
structural support for bone tissue and can be subsequently colonized by host tissue-specific
cells. One of the most investigated groups of biomaterials are degradable polymers that
naturally decompose in tissues with time. In particular aliphatic polyesters such as
polylactides were reported to fulfill biocompatibility requirements as they induce a minor or
lack an immune response and integrate with the surrounding tissue. Here we report on the
biological effects of two polymers: poly(L-lactide) (PLLA) and a copolymer of L-lactide and
trimethylene carbonate (PLTMC) on osteoblasts (MG-63) and fibroblasts (L-929).
Osteoblasts are bone forming cells that are in the closest contact with the potential implant
while fibroblasts produce the stroma forming the extracellular matrix (ECM) and along with
macrophages initiate inflammation. We detected that both types of cells adhered better to
PLLA than to PLTMC which might be related to the more rough surface of the former.
However, both polymers, but especially PLTMC, increased apoptotic death of both cell
types. Moreover, in contrast to PLLA, PLTMC modulated the production of some
immune-related mediators by fibroblasts: it increased nitric oxide production and synthesis
of numerous pro-inflammatory factors, cytokines (TNF-a and IL-6) activating leukocytes,
and ECM-degrading MMP-9 which facilitates leukocyte migration. Thus, overall, our data
suggest that PLTMC is less cytocompatible than PLLA.
Key words: Biodegradable polymers, MG-63, L-9292, adhesion, cytokines, MMP-9.
Anna SCISLOWSKA-CZARNECKA, Department of Anatomy, Academy of Physical Education,
Jana Pawla II 78, 31-571 Kraków, Poland.
E-mail: scis@poczta.onet.pl
Elzbieta PAMULA, Department of Biomaterials, AGH University of Science and Technology,
A. Mickiewicza, 30 30-59 Kraków, Poland.
Elzbieta KOLACZKOWSKA, Department of Evolutionary Immunology, Jagiellonian Univer-
sity, Gronostajowa 9, 30-387 Kraków, Poland.
Bone tissue engineering is currently one of the
fastest growing fields within regenerative medicine
aimed at developing technology for successful and
safe bone tissue replacement (LEWANDOWSKA-
SZUMIEL & WOJTOWICZ 2011). Different types of
materials have been tested for bone tissue heal-
ing/repair. However, one of the revolutionary con-
cepts in the field of biomaterials was the introduc-
tion of polymers intended to degrade within the
body after temporarily serving as either (i) struc-
tural scaffolds, (ii) matrices for controlling drug
release, or (iii) extracellular matrix substitutes con-
trolling the regeneration of tissue (LENDLEIN et al.
2011; SHASTRI & LENDLEIN 2009). One group of
promising polymers are those derived from
aliphatic polyesters. In particular, poly(L-lactide)
(PLLA or polylactic acid) has a good record of safe
use in humans and with a wide range of applica-
tions (CAMERON & SHAVER 2011; PALM &
GOLDMAN 2009). While most PLLA properties
are optimal, it also possesses some less favorable
features, e.g. its degradation time in vivo is very
long (> two years) and depends on the size of the
device (PANG et al. 2011). Moreover, although nu-
merous studies suggest that PLLA is sufficiently
biocompatible (HOLLINGER 1983; NELSON et al.
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1977) there are some studies that suggest otherwise
(VAN SLIEDREGT et al. 1994; VERHEYEN et al.
1993). Because of this there is a constant need for
novel PLLA-based polymers with improved prop-
erties and of potential clinical and commercial ap-
plication. Poly(trimethylene carbonate) (PTMC) is
an elastomeric material used in biomedical applica-
tions (GUNATILLAKE et al. 2006), although simi-
larly to the majority of aliphatic polycarbonates, it
becomes soft in the temperature range 40-60°C
and has rather weak mechanical properties. How-
ever, one of the important advantages of PTMC is
its degradation products – diols which are less
acidic than lactic acid produced as a result of
PLLA hydrolytic degradation (GUNATILLAKE et al.
2006; ZHANG et al. 2006). It was already shown
that copolymerization of L-lactide with trimethyl-
ene carbonate resulted in materials with tunable
hydrolytic degradation depending on the molar ra-
tio of both components and parameters of the syn-
thesis including temperature and time (HUA et al.
2009). This opens the possibility of producing
novel biocompatible polymers with degradation
kinetics better adjusted to bone tissue healing and
regeneration. In the work presented here we tested
if a copolymer of L-lactide and trimethylene car-
bonate (PLTMC) will show improved cytocom-
patibility as compared to the initial homopolymer
of L-lactide (PLLA) as evidenced by weaker body
cell activation and a lower mediator release.
In particular, we tested the impact of PLLA and
PLTMC on two cell populations, fibroblasts and
osteoblasts. Fibroblasts are major stromal/connec-
tive tissue cells, providing structural support for
tissues and producing extracellular matrix (ECM)
(ENZERINK & VAHERI 2011). On the other hand,
osteoblasts are specialized fibroblasts that in addi-
tion to fibroblastic products express e.g. bone sia-
loprotein, osteocalcin, osteonectin, osteopontin
and secrete bone-matrix proteins, thus promoting
bone mineralization (CAETANO-LOPES et al. 2009).
Despite the fact that both cell types synthesize
ECM, they are also capable of its degradation via
matrix metalloproteinases (MMP) the release of
which allows for tissue remodeling. Fibroblasts
and osteoblasts are also recognized as cells capa-
ble of cytokine (both pro- and anti-inflammatory)
and chemokine synthesis that can trigger inflam-
mation and activate leukocytes (CAETANO-LOPES
et al. 2009; YASZAY et al. 2001).
In the current study we used two reference cell
lines: mouse L-929 fibroblasts and human MG-63
osteoblasts, and we evaluated cell viability (in-
cluding an assessment of apoptosis), adherence,
and synthesis of nitric oxide (NO), proteins (in to-
tal), and especially of cytokines/chemokines, and
matrix metalloproteinase 9 (MMP-9).
Overall our data indicate that although both
polymers are moderately cytotoxic (induction of
cell apoptosis), it is PLTMC that is more immuno-
genic than PLLA towards fibroblasts and osteo-
blasts. Therefore our in vitro studies show that the
copolymerization of L-lactide with trimethylene
carbonate might not result in polymeric material
with improved cytocompatibility towards the two
cell types. This issue is discussed in the light of




A copolymer of L-lactide and trimethylene car-
bonate (PLTMC, 50:50) was synthesized by ring-
opening polymerization of L-lactide (Purasorb L,
Purac, The Netherlands) and 1,3-trimethylene car-
bonate (Boehringer Ingelheim, Germany), in the
presence of low-toxic initiator Zr(acac)4 (Aldrich,
Germany) – at a molar ratio of 1.25 x 10-3 at 100ºC
by a conventional method using a vacuum line for
degassing and sealing of the ampoules, as described
previously in detail (DOBRZYNSKI et al. 2006;
SCISLOWSKA-CZARNECKA et al. 2012). The syn-
thesized PLTMC had an average molecular weight
of 65 kDa, polydispersity index (d) of 1.8, and the
following molar ratios of comonomers in the co-
polymer: expected (Ne=50:50) and as determined
by 1H NMR (Nm=52:48) (SCISLOWSKA-CZARNECKA
et al. 2012).
Poly-L-Lactide (PLLA) with a viscosity-average
molecular weight Mv of 410 kDa was purchased
from Purac (The Netherlands). The chemical
structure of the two polymers is presented in Fig. 1.
The PLLA and PLTMC foils were cast from a
10% (w/v) polymer solution in methylene chloride
(POCh, Gliwice, Poland) on glass Petri dishes, fol-
lowed by air drying for 24 h and vacuum drying for
the next 72 h. Then, the foils were rinsed with ultra
high purity water (UHQ-water of the resistivity of
18.2 MScm, produced by Purelab UHQ, Elga,
UK) for 12 h. UHQ-water was exchanged 6 times.
Afterwards, the foils were air and vacuum dried
for 24 h and 72 h, respectively. The resulting foils
had a thickness of 0.18 mm. For all experiments
the bottom surface of the foils, contacting the glass
during the preparation process, was used.
Detailed characteristics of the materials were
published previously SCISLOWSKA-CZARNECKA
et al. 2012) and included: composition of copoly-
mers, molecular weights, thermal properties (glass-
transition temperature (Tg) and melting temperature
(Tm)), surface chemical composition, contact angles,
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surface free energies (SFEs), topography measure-
ments, average roughness (Ra). In brief, both poly-
mers were semicrystalline with Tg=92.5oC and
Tm=199.5oCforPLLAandTg=30.7oCandTm=149.8oC
for PLTMC. Wettability studies showed that the
polymers had similar values of total surface free
energy. Topography analysis by atomic force mi-
croscopy revealed that the foils were quite tex-
tured, especially PLLA, where typical spherulitic
structures were observed. As a result, the average
roughness of PLLA and PLTMC was relatively
high, i.e. 160 ± 12 nm and 36 ± 11.5 nm, respectively
(SCISLOWSKA-CZARNECKA et al. 2012).
Cell cultures
The murine fibroblast L-9292 and human osteo-
blast MG-63 cell lines were used in the studies.
The cells were cultured in 75 ml plastic bottles
(Nunc, Denmark) in DMEM culture medium en-
riched with glucose, L-Glutamine (PAA, Austria),
10% foetal bovine serum (PAA, Austria) and 5%
antibiotic solution containing penicillin 10 UI/ml
and streptomycin 10 mg/ml (PAA, Austria). The
cells were cultured in an incubator (Nuaire, USA)
at 37°C and 5% of CO2. Every 2-3 days, when the
cells were forming high confluence monolayers,
the cell cultures were passaged by trypsinization
(0.25% solution of trypsin; Sigma-Aldrich, Ger-
many).
In vitro cell-biomaterial studies
For cell culture studies the polymeric foils were
washed in 70% ethanol, sterilized with UV irradia-
tion (45 min for each side) and placed at the bottom
of 24-well dishes (Nunc, Denmark). The cells that
were harvested after 7 to 10 passages were counted
in Bürker’s hemocytometer, diluted to 3x104
cell/ml, and placed in the wells of 24-well culture
dishes containing discs of the tested biomaterials.
Tissue-culture polystyrene (TCPS; Nunc, Den-
mark) was used as a control material. Under these
conditions the cells were cultured for 3 or 5 days.
Subsequently, the morphology of cells adhering to
the polymeric foils was observed under an inverted
microscope (Jenamed, Germany) and was further
verified by the crystal violet staining test. Alterna-
tively, the ratio of apoptotic and/or necrotic cells
was estimated. The supernatants were collected
and frozen at -20oC prior to further analyzes of in-
flammatory mediator content. Data from 3 inde-
pendent experiments were averaged and reported.
Cell adherence and proliferation
The ability of the cells to adhere to TCPS or
polymeric surfaces was tested using the crystal
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Fig. 1. Chemical structure of poly(L-lactide) (PLLA) and poly(L-lactide-co-trimethylene carbonate) (PLTMC).
violet test (CV). The cells adhering to the tested
materials were fixed with 2% paraformaldehyde
for 1 h, and then stained with crystal violet (CV
0.5% in 20% methanol, for 5 min). Afterwards the
wells were washed with water and their content
was transferred to a new 24-well culture plate. Af-
ter drying, the absorbed dye was extracted by the
addition of 1 ml of 100% methanol (POCh, Gli-
wice, Poland). The optical density (O.D.) was
measured at 570 nm with the Expert Plus spectro-
photometer (Asys Hitach, Austria). Since the
polymers absorb some crystal violet, additional
controls containing polymeric foils and cell-free
medium were run. The O.D. results from these
controls were subtracted from the experimental data.
Cell apoptosis and necrosis
Apoptotic cells were identified quantitatively
using the Annexin V-PE Apotosis Detection Kit I
(BD Pharmingen, USA) that enables cell staining
with Annexin V and 7-Amino-actinomycin (7-AAD).
Annexin V binds to phosphatidylserine exposed on
the outer leaflet of the plasma membrane of
apoptotically dying cells while 7-AAD is a vital dye
that enters all dead cells. The cells detached by
trypsinization from polymers were stained with the
kit according to the established protocol (KO-
LACZKOWSKA et al. 2009; KOLACZKOWSKA et al.
2009a). Briefly, the cells were washed twice with
cold PBS and resuspended in binding buffer (0.1 M
HEPES/NaOH (pH 7.4), 1.4 M NaCl, 25 mM
CaCl2). Then 2.5Fl of Annexin V-PE and 2.5Fl of
7-AAD were added to the cells (105 cells/100 Fl
binding buffer) and incubated for 15 min at room
temperature in the dark. Measurements were per-
formed by a flow cytometer using CellQuest soft-
ware (FACS Caliber; Becton Dickinson). The
Annexin V-PE signal was measured in FL-2 and
the 7-AAD in FL-3 channels. Dying cells were dis-
tinguished on the basis of the FL-2/FL-3 signals:
early apoptotic Annexin V+/7-AAD-; late apop-
totic Annexin V+/7-AAD+; necrotic cells Annexin
V-/7-AAD+; alive cells Annexin V-/7-AAD-.
Inflammatory mediators in cell supernatants
Determination of nitrite/nitrate
The total amount of NO (NO2- and NO3-) was
measured as described previously (KOLACZKOWSKA
et al. 2008). Briefly, nitrate was reduced to nitrite
by addition of nitrate reductase, FAD and NADPH
(all from Sigma-Aldrich, Germany) and then
NADPH was oxidized by lactate dehydrogenase in
the presence of sodium pyruvate (both from
Sigma-Aldrich, Germany). Finally, nitrite concen-
tration in the samples was measured by the Griess
reaction, by adding Griess reagents (0.1% naph-
thalethylenediamine dihydrochloride in H2O and
1% sulphanilamide in 5% concentrated H3PO4; 1:1
vol/vol) in a ratio of 1:1 to samples and standards.
Sodium nitrite solution was used as an internal
control for the Griess assay and NaNO3 (both from
Sigma-Aldrich, Germany) as controls for the re-
duction step. The NO levels were measured at
540 nm with a Expert Plus spectrophotometer
(Asys Hitech, Eugendorf, Austria).
Determination of protein concentration
Protein concentration in the supernatants col-
lected from cell cultures was measured by the col-
orimetric BCA method. A mixture of copper (II)
sulfate solution (CS, Sigma-Aldrich, Germany)
and bicinchoninic acid solution (BCA; Sigma,
Germany) in a ratio of 1:50 was first prepared.
Subsequently, 10 Fl of each tested sample was
transferred to wells of a 96-well plate and then 200Fl
of the CS/BCA mixture was added. The plates
were incubated for 30 min in the dark. The optical
density was measured at 570 nm with an Expert
Plus spectrophotometer (Asys Hitach, Austria).
MMP-9 activity: gelatin zymography
Zymography was performed as described before
(KOLACZKOWSKA et al. 2006). Briefly, samples
of supernatant were normalized for protein con-
centration. Then the exudates were electrophore-
sed in 10% SDS-polyacrylamide gels, containing
1% porcine gelatin, (Sigma-Aldrich, Germany)
with non-reducing conditions. The gels were
washed twice in 2.5% Triton X-100 (15 min each)
and developed overnight at 37°C in incubation buffer
(50 mM Tris-HCl, pH 8.0, 5 mM CaCl2, 0.02%
NaN3, 1FM ZnCl2). The gels were fixed and stained
with 0.5% Coomassie brilliant blue (Sigma-
Aldrich, Germany) in acetic acid/isopropanol/dis-
tilled water 1:3:6, and then washedin equilibrating so-
lution with 40% methanol, 10% acetic acid and 3%
glycerol (all from Sigma-Aldrich, Germany). Pro-
tein bands with gelatinolytic activity appeared as
clear lysis zones within the blue background of the
gelatin gel. The degradation of gelatin was visual-
ized under long wave UV light. A pre-stained
broad range molecular weight standard (Bio-Rad,
USA) was used. Densitometric analysis of protein
bands was performed through the use of the
UVISoft-UVIMap program (UVItec, Ltd.,UK).
Determination of cytokines/chemokines
by Cytometric Bead Array (CBA)
Cytometric Bead Array sets (Mouse Inflamma-
tion Kit and Human Inflammatory Cytokines Kit,
CBA; BD Biosciences) were used to study cytoki-
A. SCISLOWSKA-CZARNECKA et al.14
nes and chemokines in supernatants as described
before (KOLACZKOWSKA et al. 2008). A mouse
inflammation kit simultaneously detects mouse
IL-6, IL-10, MCP-1, IFN-ã, TNF-á, and IL-12p70
and the human kit identifies IL-8, IL-1$, IL-6, IL-10,
TNF-á, IL-12p70. Both kits were used according
to the manufacturer’s instructions. Briefly, a mix-
ture of 6 capture bead populations (50 Fl) with dis-
tinct fluorescence intensities (detected in FL3) coated
with antibodies specific for the above cytokines/che-
mokines was mixed with each sample/standard(50Fl).
Additionally, PE-conjugated detection antibodies
(detected in FL-2; 50 Fl) were added to form sand-
wich complexes. After the 2-h incubation (in the
dark) the samples were washed once (200 g, 5 min)
and resuspended in 300 Fl of wash buffer before
acquisition on a FACScan cytometer (FACSCali-
bur flow cytometer, Becton Dickinson, USA). Fol-
lowing acquisition of data by two-colour cytomet-
ric analysis, the sample results were analysed using
CBA software (BD Biosciences, USA). Standard
curves were generated for each cytokine using the
mixed cytokine/chemokine standard provided by
the kit. The concentration of each cytokine in cell
supernatants was determined by interpolation
from the corresponding standard curve.
Statistical analysis
Results are expressed as means ± SE. Statistical
significance was determined by one way analysis of
variance (ANOVA) followed by a post hoc T-Tukey
test and the differences were regarded as signifi-
cant at p<0.05. At the beginning of each experi-
ment the cell numbers were the same (3x104/ml in
each well). However, upon incubation of cells with
some of the tested polymers their numbers signi-
ficantly changed in time and this is reflected by
changes in numbers of adhering cells (Fig. 1A, Fig.
1B) as fibroblasts and osteoblasts must adhere in
order to survive (ANSELME 2000). Therefore, the
levels of released inflammatory mediators might
be a direct consequence of changes in cell num-
bers, thus all data were recalculated to cell adher-
ence results (parameter/cell adherence). A letter-
-code on the figures is used to show statistically sig-
nificant differences according to ANOVA. Letters
(a, b, c or A, B, C) express statistical significance
and are randomly chosen. The letter-code should
be understood as follows: the values that are sig-
nificantly different according to ANOVA are
marked with different letters (e.g. “a” and “b” ;
“A” and “B”) while the values sharing the same
letter (e.g. “a” and “ab”, “a” and “a”) are similar,
i.e. not statistically different. Differences between




On days 3 and 5 of experiments MG-63 osteo-
blasts cultured on PLLA showed increased adher-
ence in comparison to cells cultured on control
TCPS (Fig. 2A). This effect was not observed in
the case of PLTMC (Fig. 2A). L-929 fibroblasts
incubated with PLTMC for 3 days showed signifi-
cantly lower numbers of adhering cells while
5-day incubation with PLLA led to significantly
increased fibroblast adherence in comparison to
the control TCPS (Fig. 2B). In the case of all three
tested biomaterials the osteoblast and fibroblast
adherence increased in time and was higher on day
5 than on day 3.
Apoptotic cells
In comparison to TCPS a significantly higher ra-
tio (percentage) of early apoptotic cells was ob-
served on days 3 and 5 when osteoblasts (Fig. 3A)
and fibroblasts (Fig. 3B) were incubated with ei-
ther PLLA or PLTMC. The ratio of late apoptotic
cells was unaltered in comparison to TCPS.
Moreover, we did not detect significant differ-
ences in numbers of necrotic osteoblasts and fibro-
blasts among cells incubated on the control
material and on PLLA or PLTMC (data not
shown).
Protein content
Osteoblasts co-cultured with PLLA for 5 days,
and with PLTMC for 3 or 5 days, released signifi-
cantly less proteins than the cells incubated with
the control TCPS (Table 1 left upper panel). Statis-
tical analysis showed that on both days of fibro-
blast incubation with PLTMC an increased
secretion of proteins was detected in comparison
to the control. On the other hand, co-culture of fi-
broblasts with PLLA increased secretion on day 3
but decreased protein release on day 5 (Table 1
right upper panel).
Nitric oxide production
Release of (NO) from osteoblasts was decreased
on day 3 in the presence of PLTMC and on day 5 in
the presence of both polymers (Table 1 left lower
panel). Culturing of fibroblasts on PLTMC in-
creased production of NO in comparison to the
control on days 3 and 5, while incubation with
PLLA decreased production of NO (Table 1 right
lower panel).
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MMP-9 release and activation
On day 3 of experiments osteoblasts cultured on
PLLA and PLTMC showed unchanged production
of pro-MMP-9 and MMP-9 (Fig. 4A). However,
5-day cultures of osteoblasts in the presence of
both investigated polymers significantly de-
creased pro-MMP-9 levels, while the levels of ac-
tive MMP-9 were unchanged (Fig. 4A).
In comparison to TCPS, production of pro-
MMP-9 and active MMP-9 by fibroblasts cultured
on PLTMC was enhanced on day 3 (Fig. 4B). No
MMP-9 production by fibroblasts was detected on
day 5 in any group.
Cytokine levels
Cytokine production by MG-63
In comparison to the control (TCPS) the secre-
tion of pro-inflammatory TNF-" by osteoblasts
cultured with the PLLA and PLTMC was de-
creased on days 3 and 5 (Fig. 5A) while that of IL-6
(Fig. 5C) and IL-8 (Fig. 5E) was lower on day 5.
On day 3 MG-63 cells cultured on both tested
polymers showed decreased production of IL-1$,
while on day 5 PLTMC increased levels of IL-1$
(Fig. 5B). Synthesis/release of IL-12p70 by
MG-63 was decreased by PLTMC and PLLA on
Fig. 2. Effects of polymers on adherence of osteoblasts MG-63 and fibroblasts L-929. Cell adherence of (A) MG-63 and (B)
L-929 on tissue culture polystyrene (control) and on polymers: poly(L-lactide) (PLLA), poly(L-lactide-co-trimethylene
carbonate) (PLTMC) after 3- and 5-day culture. The results are presented as means SE (data from 3 independent
experiments). Different letters (e.g. A versus B or a versus b) indicate statistically significant differences between the groups
according to ANOVA. Asterisks indicate statistical differences between day 3 and 5 *P<0.05; **P<0.01.
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Fig. 3. Cell death by apoptosis of MG-63 osteoblasts and L-929 fibroblasts in the presence of the tested polymers. Numbers of
apoptotic cells (at the early and late stages of apoptosis) (A) MG-63 cells and (B) L-929 cells incubated on tissue culture
polystyrene (control) and on polymers: poly(L-lactide) (PLLA) and poly(L-lactide-co-trimethylene carbonate) (PLTMC) for
either 3 or 5 days. Representative dot blots for day 3 are presented above the figures. The results are presented as means SE
(data from 3 independent experiments). Different letters (e.g. A versus B, a versus b on day 3 or A versus B, a versus b on day 5)
indicate statistically significant differences between the groups according to ANOVA.
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Fig. 4. Release of pro-MMP-9 zymogen and its activation to MMP-9 by osteoblasts MG-63 and fibroblasts L-929 in the
presence of the tested polymers. Relative expression of pro- and active MMP-9 released from (A) MG-63 and (B) L-929 cells
cultured on control tissue culture polystyrene (control) and on polymers: poly(L-lactide) (PLLA) and
poly(L-lactide-co-trimethylene carbonate) (PLTMC) for 3 or 5 days. Representative gel images for day 5 are presented above
figures. The results are presented as means SE (data from 3 independent experiments). Different letters (e.g. versus b or
A versus B) indicate statistically significant differences between the groups according to ANOVA.
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Fig. 5. Synthesis of pro- and anti-inflammatory cytokines by MG-63 osteoblasts in the presence of the tested polymers. Levels
of pro-inflammatory cytokines (A) TNF-", (B) IL-1$, (C) IL-6, (D) IL-12p70, (E) IL-8 and (F) IL-10 were measured in
supernatants from MG-63 cells cultured on control tissue culture polystyrene (CTR) and on polymers: poly(L-lactide) (PLLA)
and poly(L-lactide-co-trimethylene carbonate) (PLTMC) for 3 or 5 days. The results are presented as means SE. Different
letters (e.g. A versus B or a versus b) indicate statistically significant differences between the groups according to ANOVA.
Asterisks indicate statistical differences between day 3 and 5 *P<0.05; **P<0.01.
Table 1
Production/release of proteins (total amount) and nitric oxide (NO) by MG-63 osteoblasts
or L-929 fibroblasts in the presence of the tested polymers. PLLA: poly-L-lactide, PLTMC:
poly(L-lactide-co-trimethylene carbonate), TCPS: tissue culture polystyrene (control). Levels of
NO and total protein content were measured in supernatants collected from osteoblasts (MG-63)
and fibroblasts (L-929) cultured in the presence of the polymers for either 3 days or 5 days.
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days 3 and 5, respectively (Fig. 5D). In comparison
to the control, production of anti-inflammatory
IL-10 was significantly lower in the presence
PLTMC on day 3 only (Fig. 5F).
Cytokine production by L-929
In the presence of PLTMC secretion of pro-
inflammatory IL-6 and TNF-" increased on day 5
and on day 3, respectively (Fig. 6C). Enhanced
synthesis of the chemokine MCP-1 was detected
on day 3 in the presence of PLLA, but was lower in
5-day cultures with PLTMC, in comparison to
TCPS (Fig 6E). Incubation of fibroblasts with
PLLA and PLTMC did not have a significant ef-
fect on IFN-( (Fig. 6B) and IL-12p70 (Fig. 6D)
synthesis/release on days 3 and 5 in comparison to
the control. PLTMC significantly increased syn-
thesis of anti-inflammatory IL-10 on both investi-
gated days (Fig. 6F).
Discussion
Orchestrated interactions between the cellular
milieu and biomaterial are required for the proper
functioning of the material, incorporation into the
body tissue, as well as its resistance to tissue dam-
age induction or infection (BARBUL 1990; HENKE
et al. 1998). The two latter processes are collec-
tively known as inflammation and the occurrence
of either leads to leukocyte activation and produc-
tion of pro-inflammatory mediators (reactive oxy-
gen species, cytokines/chemokines) which in the
least favorable situation might induce biomaterial
rejection because of low biocompatibility (MAJNO
& JORIS 2004). In line with this, adequate struc-
tural/stromal cell functioning is essential for the
normal healing and tissue integration of the im-
planted biomaterial, and elevation of pro-
Fig. 6. Synthesis of pro- and anti-inflammatory cytokines by L-929 fibroblasts in the presence of the tested polymers. Levels of
pro-inflammatory cytokines (A) TNF-, (B) IFN-, (C) IL-6, (D) IL-12p70, (E) chemokine MCP-1, (F) IL-10 were measured in
supernatants from L-929 cells cultured on control tissue culture polystyrene (CTR) and on polymers: poly(L-lactide) (PLLA)
and poly(L-lactide-co-trimethylene carbonate) (PLTMC) for 3 or 5 days. The results are presented as means SE. Different
letters (e.g. A versus B or a versus b) indicate statistically significant differences between the groups according to ANOVA.
Asterisks indicate statistical differences between day 3 and 5 *P<0.01; **P<0.01.
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inflammatory mediators may affect local tissue
homeostasis.
Here we show that the two tested polymers,
PLLA and PLTMC, compared to the reference
TCPS differentially affect fibroblasts/osteoblasts.
In particular, we detected that in the case of both
cell populations adhesion onto polymeric surfaces
was better on PLLA than on PLTMC or TCPS.
This effect might be explained by some properties
of these materials as they vary in surface topogra-
phy and characteristics due to differences in their
chemical structure (compare Fig. 1). In particular,
both polyesters are rather textured but the average
surface roughness of PLTMC is lower than that of
PLLA; and such properties were reported to sup-
port proper cell adherence (SCISLOWSKA-CZARNECKA
et al. 2012). The behavior of cells in contact with
the material, especially with its surface, relates di-
rectly to its biocompatibility (ANSELME 2000;
CHOU et al. 1995). This is because the quality of
the first cell-material contact influences the capac-
ity to proliferate and function at the material/bio-
logical milieu interface. The test used by us for
adherence utilizes crystal violet (a cytochemical
stain that binds to chromatin) and the assay is also
considered as an indirect measurement of cell pro-
liferation (CHATURVEDI et al. 2007). Thus, from
this point of view, PLLA seems to be the most
preferable for either fibroblast or osteoblast prolif-
eration. Nevertheless, it should be pointed out that
both cell types adhered and proliferated on the
PLLA and PLTMC surfaces maintaining their
characteristic morphology (not shown). However,
the polymers were not irrelevant for the tested cell
populations because significantly increased apop-
tosis of both cell types was detected on either day 3
or day 5. Especially on day 5, up to one third of the
tested cells was apoptotic in the presence of either
PLLA or PLTMC; this value was not higher than
5% for TCPS. Among the dying cells, the majority
was just entering the death pathway (early apop-
totic cells; Annexin V+/7-AAD-) which means
these were not cells that died some hours/days be-
fore and accumulated in the culture dish but were
dying in real time. The induction of apoptosis
might be a consequence of the cytotoxicity of the
material and has been observed in previous stud-
ies, e.g. when the effects of poly(L-lactide) were
tested on macrophages (TH-1 cell line) (POTNIS et
al. 2011). We have also observed that PLLA and
PLTMC affected macrophage (RAW.264 cell
line) viability as demonstrated by evaluation of
apoptotic cells (SCISLOWSKA-CZARNECKA et al.
2012). Thus it seems that both polymers show
some level of cytotoxicity towards different types
of cells when cultured in different conditions.
The appearance of a foreign body in a living or-
ganism provokes an inflammatory response aimed
at eliminating it by means of multiple pro-
inflammatory mediators (MAJNO & JORIS 2004;
REUTER et al. 2011). During the so called respira-
tory burst, different reactive oxygen species are
generated that might evoke a cascade of signals
leading to several intracellular events, including
apoptosis (BAYIR & KAGAN 2008). For this we
tested the production of NO that might impact the
cell cycle by inhibiting electron transport chain
complexes in mitochondria (PROTTI & SINGER
2006). We observed some correlation between the
release of NO and the ratio of apoptosis, i.e. en-
hanced apoptosis was accompanied by higher NO
levels detected in supernatants from L-929 fibro-
blasts when they were cultured with PLTMC for
5 days. However, PLTMC lowered NO release by
osteoblasts and also PLLA had a down-regulating
effect on both cell populations in terms of NO pro-
duction. Therefore a direct association between
NO production and the rate of apoptosis in the
tested system cannot be postulated. Limited data is
available on nitric oxide release by cells cultured
in the presence of PLLA and PLTMC but for ex-
ample, in a study by Liu and co-workers (2010),
human umbilical vein endothelial cells (HUVECs)
cultured on poly(D,L-lactide) were also stimu-
lated to synthesize NO (LIU et al. 2011).
In physiological conditions fibroblasts and os-
teoblasts produce differential factors, including
growth factors and MMPs (CAETANO-LOPES et al.
2009; ENZERINK & VAHERI 2011) but their activ-
ity might change upon biomaterial implantation.
We show that the release of proteins (measured as
their total content in supernatants) by either cell
population was altered by the polymers. In the case
of osteoblasts the two materials, and especially
PLTMC, rather decreased protein synthesis. The
effect on fibroblasts was less coherent, PLTMC in-
creased protein release on both days of culture
while PLLA enhanced it on day 3 but decreased it
on day 5. Moreover, we revealed that levels of cy-
tokines/chemokines were particularly affected. In
particular, PLLA down-regulated the synthesis of
numerous cytokines on day 3 (TNF-", IL-1$,
IL-10) and 5 (TNF-", IL-6, IL-8, IL-12) by osteo-
blasts while in most cases it had no effect on fibro-
blast cytokine release, except of transiently (on
day 3 only) enhanced MCP-1 production. This is
in line with data on total protein synthesis in the
presence of PLLA which generally decreased in
the osteoblast cultures on day 5 but was higher on
day 3 in the fibroblast cultures. Thus the above
data suggest that PLLA shows only a moderate en-
hancing effect on the synthesis of pro-
inflammatory cytokines/chemokines. On the other
hand, in the case of PLTMC this is more complex
because of the reduced production of some cytoki-
nes (e.g. TNF-", IL-6, IL-8, IL-12) in osteoblasts
in the presence of this polymer, although the syn-
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thesis of potent IL-1$ was differentially affected
(lower on day 3 but higher on day 5). Moreover,
PLTMC enhanced the production of pro-inflammatory
TNF-" and IL-6 and anti-inflammatory IL-10 by
fibroblasts, therefore revealing an overall more
pro-inflammatory character than PLLA.
The two polymers also affected the synthesis of
MMP-9. The main function of this protease is deg-
radation of denatured collagens, including base-
ment membrane collagens of type IV and as such
the regulation of leukocytosis which is a highlight
of the inflammatory response (OPDENAKKER et al.
2001). Only PLTMC increased MMP-9 produc-
tion by fibroblasts which further suggests its po-
tential pro-inflammatory behavior. Nevertheless,
MMP-9 synthesis by fibroblasts was detected only
on day 3, thus the unwanted impact of PLTMC
should not have a long-term effect. On the other
hand, both tested polymeric materials decreased
MMP-9 release from osteoblasts on day 5 of cul-
ture. In the case of bone cells the role of MMP-9 is
more complex as it cooperates with another gelati-
nase, MMP-2, in bone remodeling Therefore we
can speculate that in our system the decrease of
MMP-9 synthesis by osteoblasts might signal the
possibility of impaired bone remodeling in the
presence of PLLA and PLTMC.
In general, the results on mediator production in-
dicate that the inflammatory response induced in
the presence of PLTMC is rather strong and could
activate leukocytes. In contrast, the impact of
PLLA was much more moderate as only the pro-
duction of chemokine MCP-1 was transiently ele-
vated in fibroblasts. However, MCP-1 is a known
monocyte/macrophage factor attracting those cells
to the site of foreign body invasion/implantation
(AJUEBOR et al. 1998). The communication be-
tween fibroblasts and macrophages, both being the
primary effector cells in the response to a foreign
body, is well documented and involves soluble
factors and direct cell-cell contacts (HOLT et al.
2011). The two cell types might also be co-
involved in implant degradation and fibrosis. In
line with this we showed previously that PLTMC,
butnotPLLA, increasedsynthesisofpro-inflammatory
IFN-( and IL-12p70 by macrophages in vitro
(SCISLOWSKA-CZARNECKA et al. 2012).
In the majority of previous studies PLTMC was
reported to be a biocompatible and biodegradable
material. For example, Pego and co-workers
(2003) have used different copolymers of PLTMC
(20 or 50 mol% of 1,3-trimethylene carbonate) to
develop three-dimensional scaffolds for soft tissue
engineering. Their in vitro cell seeding studies
showed that rat cardiomyocyte cells attached and
proliferated well on this copolymer (PEGO et al.
2002; PEGO et al. 2003a). Moreover, PLTMC had
good resorption properties in vivo, and only a mild
tissue response was observed (PEGO et al. 2003b,
PEGO et al. 2003c).
However, it should be pointed out that in the
above study as well as in other numerous reports
only limited immunological parameters (if any)
were studied. For example, MUKHERJEE and co-
workers (2011) provide an investigation of the bio-
logical effects of PLTMC (70:30) on myocardial
cells that was limited to their proliferation, mor-
phology and specific cell markers. A similar ap-
proach was undertaken by Ji and colleagues (2010)
when studying the effects of PLTMC (85:15) on
mouse NIH/3T3 fibroblasts (Ji et al. 2010). Both
studies described improved adherence of the in-
vestigated cells although no immunological pa-
rameters were evaluated while, as revealed in our
studies, the cells might adhere in an uncompro-
mised manner and yet be active in the potent im-
mune response (MUKHERJEE et al. 2011; JI et al.
2010).
One of the few studies in which immunological
parameters were evaluated was performed in vivo
and PLTMC/PLLA were implanted subcutane-
ously (GUO et al. 2011). Fewer immune cells infil-
trated tissues around PLTMC than in the PLLA
implanted rats (GUO et al. 2011). However, some
macrophage infiltration was observed in a study in
which the polymers were implanted into rat perito-
neal cavity (DARGAVILLE et al. 2011).
On the other hand, a small number of studies re-
vealed that PLTMC might have some significantly
unfavorable effects on the investigated cells/tissues.
One of the most important of them is a clinical
follow-up case study reporting delayed foreign-
body reaction to absorbable implants, including those
consisting of trimethylene carbonate and L-lactide
(GIVISSIS et al. 2010). The study reveals that the
implanted polymers achieved adequate bone heal-
ing. Although at first no foreign-body (inflamma-
tory) reaction was observed, it was postponed and
occurred after a few years; requiring is some cases
implant removal (GIVISSIS et al. 2010). In in vitro
settings, the adverse effects of PLTMC were
shown previously by our group in relation to
macrophages RAW 264.7. We demonstrated that
the polymer decreased their adherence, increased
production of NO, MMP-9 and pro-inflammatory
cytokines (SCISLOWSKA-CZARNECKA et al 2012).
Overall, the data presented here suggest that in
the case of fibroblasts and osteoblasts, PLTMC
acts as a stronger immunostimulator than PLLA
leading to the generation of reactive oxygen spe-
cies and cytokines/chemokines. In addition, al-
though PLTMC is associated with rather good cell
adhesion, it is a more severe inducer of fibroblast
and osteoblast apoptosis than PLLA. Therefore
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based on our in vitro studies we can conclude that
the copolymerization of L-lactide with trimethyl-
ene carbonate (50:50) does not result in polymeric
material with improved cytocompatibility, as esti-
mated by its ability to activate the immune system,
at least towards fibroblasts and osteoblasts in our
in vitro system.
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